Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...

New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth ...

New offering empowers hospitals to enhance clinical excellence, streamline operations, and helps secure sustainable financial growth without disrupting existing clinician employment models. BRENTWOOD, ...

Marvin S. Hausman MD to discuss screening program at ASCO MIAMI, FLORIDA / ACCESS Newswire / April 29, 2025 / Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in ...

SAN JUAN CAPISTRANO, CALIFORNIA / ACCESS Newswire / April 29, 2025 / Alter Behavioral Health announces the grand opening of its new Luxury Residential Crisis Center in San Juan Capistrano. This ...

Collaboration combines Scipher's unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN's proprietary Comprehensive Pathway Analysis (CPA) ...

Integration makes Vastian the first platform to electronically incorporate the Leapfrog Hospital Survey Binder LAWRENCEVILLE, GA / ACCESS Newswire / April 29, 2025 / Vastian, a leading provider of ...

Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market LAVAL, QC / ACCESS Newswire / April 29, 2025 / Bausch Health Companies Inc.

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first quarter of 2025 on Tuesday, May 13, 2025, at 07:00 a.m. CEST.In conjunction to the ...

In 2023, the myotonic dystrophy treatment market is projected to be worth USD 874.39 million. The global demand for myotonic dystrophy treatment is anticipated to increase at a CAGR of 12.3% between ...

The global isovaleric acidemia treatment market is poised for remarkable growth, projected to rise from USD 652.28 million in 2023 to USD 1,125.15 million by 2033, reflecting a robust CAGR of 5.6%.

Miscellaneous29.04.2025 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement. Mainz Biomed Enters into Technology Partnership with EDX Medical GroupBERKELEY, US and ...